Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Subscribe To Our Newsletter & Stay Updated
